Belvedere Trading’s 89bio ETNB Stock Holding History

Belvedere Trading’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-47,949	Closed	-$730K	–	939
2023 Q1	$730K	Buy	47,949 +33,945	+242%	+$443K	﹤0.01%	102
2022 Q4	$178K	Buy	+14,004	New	+$126K	﹤0.01%	363

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Belvedere Trading's ETNB Position: Q2 2023 in Review

Belvedere Trading sold out of 89bio (ETNB) in Q2 2023, closing a stake of 47,949 shares — an estimated $730K sold.

Belvedere Trading first reported a position in ETNB in Q4 2022 and held it in 2 quarters. The position peaked at $730K in Q1 2023. 157 funds tracked by Wall St. Rank hold ETNB as of Q2 2023.

Belvedere Trading reported no remaining 89bio position as of Q2 2023 after selling out during the quarter.
Belvedere Trading sold 47,949 89bio shares in Q2 2023, an estimated $730K.
Belvedere Trading first reported a position in 89bio in Q4 2022 and held it in 2 quarters.
Belvedere Trading's 89bio position peaked at $730K in Q1 2023.
157 funds tracked by Wall St. Rank held 89bio as of Q2 2023.

Based on Belvedere Trading's 13F filing for Q2 2023, filed 8 Aug 2023.